Cautiously optimistic for the new year

07/01/25 -"Next has once again raised its FY24/25 expectations, driven by strong momentum in the UK online business and accelerated overseas online sales growth ahead of the holiday season. Looking ahead to ..."

Executive summary
Conflict of interest

Pages

Language

English

Published on

07/01/25

Download

You may also be interested by these reports :

12/02/26

Rexel

Rexel reported Q4 2025 sales in line with market expectations. The group’s organic growth was supported by solid volumes and improved pricing. North ...

12/02/26

Fielmann Group

Mixed prel. FY25 results: Sales below but adj. EBITDA met expectations

11/02/26

Redcare Pharmacy

Reduced sales expectations and lower market multiples in the total e-com sector led to our new TP of EUR 125 – BUY

10/02/26

Non-Food Retail

2025: Ranking of online pharmacies in Germany. The winner is Redcare Pharmacy, widening the gap to the rest

EXECUTIVE SUMMARY

Updates

Pension Risks

Target & Opinion

Governance & Management

Business & Trends

Graphics : Momentum

Money Making

Graphics : MACD & Volumes

Debt

Graphics : Sensitivities

Valuation

Sector: Performance

DCF

Sector: Key data

NAV/SOTP

Sector: Ratios & Valorisation

Worth knowing

Sector: Peers

Financials

Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking

Trading in corporate shares

Analyst ownership

Advising of corporate (strategy, marketing, debt, etc)

Research paid for by corporate

Provision of corporate access paid for by corporate

Link between and a banking entity

Brokerage activity at AlphaValue